GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verrica Pharmaceuticals Inc (FRA:1NE) » Definitions » Price-to-Tangible-Book

Verrica Pharmaceuticals (FRA:1NE) Price-to-Tangible-Book : 238.33 (As of May. 22, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Verrica Pharmaceuticals Price-to-Tangible-Book?

As of today (2024-05-22), Verrica Pharmaceuticals's share price is €7.865. Verrica Pharmaceuticals's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was €0.03. Hence, Verrica Pharmaceuticals's Price to Tangible Book Ratio of today is 238.33.

The historical rank and industry rank for Verrica Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

FRA:1NE' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.34   Med: 5.05   Max: 241.67
Current: 196.63

During the past 8 years, Verrica Pharmaceuticals's highest Price to Tangible Book Ratio was 241.67. The lowest was 2.34. And the median was 5.05.

FRA:1NE's Price-to-Tangible-Book is ranked worse than
99.84% of 1223 companies
in the Biotechnology industry
Industry Median: 2.85 vs FRA:1NE: 196.63

A closely related ratio is called PB Ratio. As of today, Verrica Pharmaceuticals's share price is €7.865. Verrica Pharmaceuticals's Book Value per Sharefor the quarter that ended in Mar. 2024 was €0.03. Hence, Verrica Pharmaceuticals's P/B Ratio of today is 238.33.


Verrica Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for Verrica Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verrica Pharmaceuticals Price-to-Tangible-Book Chart

Verrica Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial 6.17 9.01 7.91 2.39 15.11

Verrica Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.22 4.26 3.74 15.11 157.58

Competitive Comparison of Verrica Pharmaceuticals's Price-to-Tangible-Book

For the Biotechnology subindustry, Verrica Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Verrica Pharmaceuticals's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Verrica Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Verrica Pharmaceuticals's Price-to-Tangible-Book falls into.



Verrica Pharmaceuticals Price-to-Tangible-Book Calculation

Verrica Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=7.865/0.033
=238.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Verrica Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Verrica Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Verrica Pharmaceuticals (FRA:1NE) Business Description

Traded in Other Exchanges
Address
44 West Gay Street, Suite 400, West Chester, PA, USA, 19380
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts.

Verrica Pharmaceuticals (FRA:1NE) Headlines

No Headlines